THE USE OF ISOTRETINOIN FOR TREATING MODERATE-TO-SEVERE AND NODULOCYSTIC ACNE
Article Sidebar
Main Article Content
Abstract
This article presents data on the pathogenesis of acne, therapeutic decision-making mechanisms, the strategy for prescribing isotretinoin, and further patient management. It addresses key questions regarding the appropriate daily dosage and the importance of achieving the cumulative dose, as well as the safety profile of isotretinoin-containing medications. The article also discusses the use of high-dose vitamin A (retinol palmitate) in acne patients and the associated adverse effects. Three clinical cases of patients diagnosed with acne are presented to illustrate treatment strategies.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Gollnick H. Acne and related disorders. In: Elzouki AY, Harfi HA, Nazer H, Oh W, Stapleton FB, Whitley RJ, eds. Textbook of Clinical Pediatrics. Berlin: Springer; 2012: 1447–1466.
2. Thlboutot D, Gollnick H, Bettoli V, et al. New insights Into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009; 60: S 1–S 50.
3. 4. Paugam C, Corvee S, Saint-Jean M, et al. Propionibacterium acnés phylotypes and acne severity: an observational prospective study. J Eur Acad Dermatol Venereol. 2017; 31: e398–e399. Dreno B, Thiboutot D, Gollnick FI, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol. 2014; 24: 330–334.
5. Thiboutot D, Dreno B, Gollnick FI, et al. A call to limit antibiotic use in acne. Journal of drugs in dermatology: JDD. 2013; 12: 1331–1332.
6. Pulcini C, Gyssens IC. Flow to educate prescribers in antimicrobial stewardship practices. Virulence. 2013; 4: 192–202.
7. Bikowski JB. Subantimicrobial dose doxycydine for acne and rosacea. Skinmed. 2003; 2: 234–245.
8. Gollnick HP, Bettoll V, Lambert J, et al. A consensus-based practical and daily guide for the treatment of acne patients. J Eur Acad Dermatol Venereol. 2016; 30 (9): 1480–1490.
9. Cunliffe WJ, van de Kerkhof PC, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology. 1997; 194: 351–357.
10. Tan J, Knezevic S, Boyal S, Waterman B, Janik T. Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120–150 mg/kg. J Cutan Med Surg. 2016; 20: 13–20. 11. Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H, Exner JH. Isotretinoin therapy for acne: results of a multicenter dose response study